Johnson & Johnson (JNJ) PT, Estimates Cut at BofA/Merrill Lynch Post Q3
Tweet Send to a Friend
BofA/Merrill Lynch analyst Bob Hopkins lowered his price target on Johnson & Johnson (NYSE: JNJ) to $99.00 (from $106.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
